"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable [clinical] result” cheered Wall Street, ...

Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...

Costco Wholesale Corp. on Wednesday reported a 9.9% year-over-year sales gain through the final stretch of the holiday shopping season, marked by a big jump in online sales.

Costco Wholesale Corp. on Wednesday reported a 9.9% year-over-year sales gain through the final stretch of the holiday shopping season, marked by a big jump in online sales.

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

Specialty drugs remain the leading factor in spending, even though they represent a small fraction of overall utilization." ...

Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...

"Second quarter revenue results were exceptional, reflecting strong sales of the MindBody GLP-1 System we launched in October in the United States along with outstanding execution by our team to ...

Donald Trump threw out yet another threat of tariffs when he floated hitting Denmark with the economic punishment if it did ...

A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like ...

The study showed diabetic patients taking GLP-1 drugs, such as semaglutide and tirzepatide, faced significantly lower risks of 30-day readmission, wound re-opening and hematoma after surgery, compared ...